CIK: 0001792206 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 13, 2023
Total Value ($000): $62,679 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HIMS | Hims & Hers Health, Inc. | 3,733,381 | $23,483 | 37.5% | $8.43 | -11.8% | COM CL A | 433000106 |
| IRON | Disc Medicine, Inc. | 243,513 | $11,440 | 18.3% | $49.79 | +0.5% | COM | 254604101 |
| — | Theseus Pharmaceuticals, Inc. | 4,108,796 | $11,053 | 17.6% | $10.73 | — | COM | 88369M101 |
| ACRS | Aclaris Therapeutics, Inc. | 1,258,243 | $8,619 | 13.8% | $19.56 | -56.3% | COM | 00461U105 |
| — | Kinnate Biopharma Inc. | 3,525,957 | $4,936 | 7.9% | $13.15 | — | COM | 49705R105 |
| CMPX | Compass Therapeutics, Inc. | 1,246,977 | $2,457 | 3.9% | $3.29 | -24.8% | COM | 20454B104 |
| PHVS | Pharvaris N.V. | 33,142 | $692 | 1.1% | $31.46 | -41.4% | COM | N69605108 |